Literature DB >> 36104632

Role of Transhepatic Arterial Radioembolization in Metastatic Colorectal Cancer.

Irene Bargellini1, Elena Bozzi2, Giulia Lorenzoni2, Giuseppe Boni3, Francesca Bianchi3, Claudio Antonio Traino4, Gianluca Masi5, Roberto Cioni2, Laura Crocetti2.   

Abstract

The liver represents the most frequent location of metastatic disease in colorectal cancer (CRC). In oligometastatic disease, while surgery remains the mainstay of treatment, loco-regional therapies allow to locally control tumor progression and prolong survival. There is consensus in the use of transhepatic arterial radioembolization (TARE) in metastatic CRC chemorefractory patients, with liver-only or liver-dominant disease. Beyond this indication, TARE may be considered in other clinical scenarios, such as in the second-line combined with chemotherapy, as a bridge in between different lines of systemic therapies, and as ablative technique under specific circumstances. This paper outlines the current evidence for TARE in mCRC and presents possible future indications and directions.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Entities:  

Keywords:  Colorectal cancer; Hepatectomy; Hepatic arterially directed therapies; Holmium-166; Liver; Liver tumor ablation; Metastasis; Radioembolization; Yttrium-90

Year:  2022        PMID： 36104632     DOI： 10.1007/s00270-022-03268-y

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.797


  46 in total

1.  Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Al B Benson; Alan P Venook; Mahmoud M Al-Hawary; Mustafa A Arain; Yi-Jen Chen; Kristen K Ciombor; Stacey Cohen; Harry S Cooper; Dustin Deming; Linda Farkas; Ignacio Garrido-Laguna; Jean L Grem; Andrew Gunn; J Randolph Hecht; Sarah Hoffe; Joleen Hubbard; Steven Hunt; Kimberly L Johung; Natalie Kirilcuk; Smitha Krishnamurthi; Wells A Messersmith; Jeffrey Meyerhardt; Eric D Miller; Mary F Mulcahy; Steven Nurkin; Michael J Overman; Aparna Parikh; Hitendra Patel; Katrina Pedersen; Leonard Saltz; Charles Schneider; David Shibata; John M Skibber; Constantinos T Sofocleous; Elena M Stoffel; Eden Stotsky-Himelfarb; Christopher G Willett; Kristina M Gregory; Lisa A Gurski
Journal:  J Natl Compr Canc Netw       Date:  2021-03-02       Impact factor: 11.908

2.  Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.

Authors:  Andrew S Kennedy; David Ball; Steven J Cohen; Michael Cohn; Douglas M Coldwell; Alain Drooz; Eduardo Ehrenwald; Samir Kanani; Steven C Rose; Charles W Nutting; Fred M Moeslein; Michael A Savin; Sabine Schirm; Samuel G Putnam; Navesh K Sharma; Eric A Wang
Journal:  J Gastrointest Oncol       Date:  2015-04

3.  Colorectal cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ann Goding Sauer; Stacey A Fedewa; Lynn F Butterly; Joseph C Anderson; Andrea Cercek; Robert A Smith; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-03-05       Impact factor: 508.702

4.  Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.

Authors:  Alain Hendlisz; Marc Van den Eynde; Marc Peeters; Geert Maleux; Bieke Lambert; Jaarke Vannoote; Katrien De Keukeleire; Chris Verslype; Luc Defreyne; Eric Van Cutsem; Philippe Delatte; Thierry Delaunoit; Nicola Personeni; Marianne Paesmans; Jean-Luc Van Laethem; Patrick Flamen
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

5.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

6.  Is yttrium-90 radioembolization a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases? A large single-center experience of 302 patients.

Authors:  Akshat Saxena; Baerbel Meteling; Jada Kapoor; Sanjeev Golani; David L Morris; Lourens Bester
Journal:  Ann Surg Oncol       Date:  2014-10-17       Impact factor: 5.344

7.  Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.

Authors:  Mary F Mulcahy; Armeen Mahvash; Marc Pracht; Amir H Montazeri; Steve Bandula; Robert C G Martin; Ken Herrmann; Ewan Brown; Darryl Zuckerman; Gregory Wilson; Tae-You Kim; Andrew Weaver; Paul Ross; William P Harris; Janet Graham; Jamie Mills; Alfonso Yubero Esteban; Matthew S Johnson; Constantinos T Sofocleous; Siddharth A Padia; Robert J Lewandowski; Etienne Garin; Philip Sinclair; Riad Salem
Journal:  J Clin Oncol       Date:  2021-09-20       Impact factor: 44.544

8.  90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.

Authors:  Ryan Hickey; Robert J Lewandowski; Totianna Prudhomme; Eduardo Ehrenwald; Brian Baigorri; Jeffrey Critchfield; Joseph Kallini; Ahmed Gabr; Boris Gorodetski; Jean-Francois Geschwind; Andrea Abbott; Ravi Shridhar; Sarah B White; William S Rilling; Brendan Boyer; Shannon Kauffman; Sharon Kwan; Siddarth A Padia; Vanessa L Gates; Mary Mulcahy; Sheetal Kircher; Halla Nimeiri; Al B Benson; Riad Salem
Journal:  J Nucl Med       Date:  2015-12-03       Impact factor: 10.057

9.  ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.

Authors:  E Van Cutsem; A Cervantes; R Adam; A Sobrero; J H Van Krieken; D Aderka; E Aranda Aguilar; A Bardelli; A Benson; G Bodoky; F Ciardiello; A D'Hoore; E Diaz-Rubio; J-Y Douillard; M Ducreux; A Falcone; A Grothey; T Gruenberger; K Haustermans; V Heinemann; P Hoff; C-H Köhne; R Labianca; P Laurent-Puig; B Ma; T Maughan; K Muro; N Normanno; P Österlund; W J G Oyen; D Papamichael; G Pentheroudakis; P Pfeiffer; T J Price; C Punt; J Ricke; A Roth; R Salazar; W Scheithauer; H J Schmoll; J Tabernero; J Taïeb; S Tejpar; H Wasan; T Yoshino; A Zaanan; D Arnold
Journal:  Ann Oncol       Date:  2016-07-05       Impact factor: 32.976

10.  Improved Outcomes of Thermal Ablation for Colorectal Liver Metastases: A 10-Year Analysis from the Prospective Amsterdam CORE Registry (AmCORE).

Authors:  Robbert S Puijk; Madelon Dijkstra; Bente A T van den Bemd; Alette H Ruarus; Sanne Nieuwenhuizen; Bart Geboers; Florentine E F Timmer; Evelien A C Schouten; Jan J J de Vries; Bram B van der Meijs; Karin Nielsen; Rutger-Jan Swijnenburg; M Petrousjka van den Tol; Kathelijn S Versteeg; Birgit I Lissenberg-Witte; Hester J Scheffer; Martijn R Meijerink
Journal:  Cardiovasc Intervent Radiol       Date:  2022-05-18       Impact factor: 2.797
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.